Streetbeat News

Earnings

CLOV

Clover Health Investments (NASDAQ:CLOV) reported Q3 sales of $482.07 million, missing the analyst consensus estimate of $494.60 million by 2.53 percent. This represents a 43.74 percent decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:10 pm

FGEN

FibroGen (NASDAQ:FGEN) reported Q3 2023 earnings with losses of $(0.52) per share, beating the analyst consensus estimate of $(0.68) by 23.53%. This is a 46.94% increase over losses from the same period last year. The company also reported quarterly sales of $40.13 million, beating the analyst consensus estimate of $36.84 million by 8.94%, a 155.06% increase over sales from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 06, 2023 | 9:10 pm

HIMS

Hims & Hers Health has reported its Q3 earnings per share (EPS) at $(0.04).

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:08 pm

TRIP

TripAdvisor reported Q3 adjusted earnings of $0.52 per share, beating the analyst consensus estimate of $0.46 by 13.04%. The company also reported quarterly sales of $533.00 million, surpassing the analyst consensus estimate of $505.24 million by 5.54%. This represents a 16.12% increase over sales of $459.00 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:08 pm

HIMS

Hims & Hers Health reported Q3 revenue of $226.7M, surpassing the estimated $220.048M.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:08 pm

HIMS

Hims & Hers Health has raised its full year 2023 outlook. However, the details of the revised outlook were not provided in the article.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:06 pm

RNG

RingCentral has updated its FY23 Non-GAAP EPS forecast to $3.19-$3.20, which is higher than the estimated $3.15. The company also expects its total revenue to be between $2.198B-$2.205B, closely aligning with the estimated $2.2B.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:05 pm

FANG

Diamondback Energy (NASDAQ:FANG) reported Q3 earnings of $5.49 per share, beating the analyst consensus estimate of $4.92 by 11.59%. However, this is a 15.28% decrease from the same period last year. The company also reported quarterly sales of $2.34 billion, beating the estimate of $2.14 billion by 9.35%, but marking a 3.98% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:05 pm

AOSL

Alpha and Omega Semiconductor (AOSL) has projected its Q2 2024 revenue to be around $165M +/- $10M, which is lower than the estimated $175.57M.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:05 pm

TASK

TaskUs (NASDAQ:TASK) reported Q3 adjusted earnings of $0.32 per share, beating the analyst consensus estimate of $0.29 by 10.34%. However, this is an 8.57% decrease from the same period last year. The company also reported quarterly sales of $225.63 million, surpassing the analyst consensus estimate of $220.78 million by 2.19%, but marking a 2.80% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:05 pm